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Hyperglycemia-mediated oxidative stress plays a major role in the development of diabetic
complications.Averrhoa bilimbi Linn. (Oxalidaceae) is amedicinal plantwith fruits reported to
possess antidiabetic activity. This study evaluated the beneficial effects of the ethyl acetate
fraction of A. bilimbi fruit (ABAEE) on the antioxidant/oxidant status in diabetes mellitus.
Diabetic rats were treated orally with the ethyl acetate fraction ofA. bilimbi fruits at a dose of
25 mg/kg body weight for 60 days. Serum glucose, glycated hemoglobin, plasma insulin, he-
patic toxicity markers, antioxidant enzymes, lipid peroxidation products, and liver histopa-
thology were assayed checked after 60 days of extract treatment. Diabetic rats administered
ABAEE showed a significant decline in serum glucose, glycated hemoglobin, and also
significantly increases the level of plasma insulin, as well as a notable attenuation in thio-
barbituric acid-reactive substances, conjugated dienes, and hydroperoxides. ABAEE also
modulated hepatic antioxidant potential by significantly increasing the activities of catalase,
glutathione peroxidase, glutathione reductase, superoxide dismutase, and reducing gluta-
thione content. The results associatedwithABAEEweremore significant than thoseobserved
following treatment with the standard drug metformin. Histopathological observations
showed thatABAEEeffectively rescuedhepatocytes fromoxidativedamagewithout affecting
cellular function and structural integrity. High-performance liquid chromatography analysis
of ABAEE indicated the presence of phenolic compound, quercetin, indicating that the anti-
diabetic effect of the extract might be related to quercetin. These results demonstrated the
potential beneficial effect of ABAEE on streptozotocin-induced diabetes in rats.
Copyright © 2016, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).insulin receptor or postreceptor events, with derangement in
1. Introduction
Diabetes mellitus, a pervasive and multifactorial metabolic
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chronic hyperglycemia, a clinical hallmark of diabetes [1]. In
2011, there were 366 million people with diabetes, with thiserala, Kariavattom, Thiruvananthapuram 695 581, Kerala, India.
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j o u r n a l o f f o o d and d r u g an a l y s i s x x x ( 2 0 1 6 ) 1e92number expecting to rise to 552 million by 2030 [2]. Hyper-
glycemia describes a stage of increased blood glucose levels in
circulating blood and generates reactive oxygen species (ROS)
through various pathways, including dysregulation of redox
equilibrium, augmentation of advanced glycation products,
activation of protein kinase C, or overproduction of mito-
chondrial superoxides that eventually leads to oxidative
stress in various tissues [3].
Management of diabetes without side effects remains a
challenge. Many synthetic drugs are used in the treatment of
diabetes; however, plant-based drugs are often considered
less toxic and free of side effects. Indian traditional medicines
belong to one of the richest medicinal systems in the world.
Therefore, there is a need to search for phytocomponents that
normalize hyperglycemia and ameliorate oxidative stress for
the prevention or minimization of diabetes-associated
complications.
Averrhoa bilimbi Linn. (Oxalidaceae), commonly known as
cucumber tree or tree sorrel, is a widely cultivated plant in
India, Indonesia, Sri Lanka, Bangladesh, Myanmar,
Malaysia, and Central and South America. The entire plant
is used for treating coughs, colds, itches, rheumatism,
whooping cough, and hypertension [4,5]. Traditionally A.
bilimbi fruits are employed for curing diabetes, although no
scientific data are available concerning the antidiabetic
properties of the fruits.
Previous studies reported that A. bilimbi-leaf extract regu-
lates blood glucose and lipids in streptozotocin (STZ)-induced
diabetic rats [6]. Studies on A. bilimbi fruits in rats showed that
the fruit (125 mg/kg), as well as its water extract (50 mg/kg),
was effective in lowering lipids in rats fed a high-fat diet, and
can be used as a dietary ingredient to prevent and treat
hyperlipidemia [7]. Studies showed that the semipurified
fractions of A. bilimbi leaves exhibited antidiabetic activity in
STZ-induced diabetic rats fed a high-fat diet [8]. Our previous
studies revealed the beneficial effect of aqueous extracts of A.
bilimbi fruit in controlling blood glucose levels, improving lipid
metabolism, and preventing diabetic complications from lipid
peroxidation in experimental diabetic rats [9]. In-vitro anti-
oxidant studies of different solvent fractions (petroleum
ether, ethyl acetate, butanol, and water) of A. bilimbi fruits
revealed the superior effect elicited by the ethyl acetate
fraction.
However, no reports are available on the protective effect
of the ethyl acetate fraction of A. bilimbi fruits (ABAEE) on
hyperglycemia-mediated oxidative stress in STZ-induced
diabetic rats. Therefore, the present study investigated the
ameliorative potential of the ethyl acetate fraction ofA. bilimbi
in STZ-induced diabetic rats, and the efficacy of the ABAEE
was compared with that of metformin, a standard oral anti-
diabetic drug.2. Materials and methods
2.1. Chemicals
Chemicals were purchased from Sigma Aldrich (St. Louis, MO,
USA), Merck Chemical Company (Darmstadt, Germany), and
Sisco Research Laboratories (Mumbai, India).Please cite this article in press as: Kurup SB, Mini S, Averrhoa bilim
streptozotocin-induced diabetic rats, Journal of Food and Drug Analy2.2. Extraction of A. bilimbi fruits
Fresh fruits of A. bilimbi were obtained from Thir-
uvananthapuram, Kerala, India, during the fruiting season
(JulyeDecember 2014) and identified by Dr. Valsala Devi,
Department of Botany, University of Kerala (Voucher number:
KUBH 5865). Care was taken that the fruits, which were
whitish-green in color and ~5e7.0 cm in size, were not over-
ripe, spoiled, or damaged. Fruits (5 kg) were shade dried at a
temperature of 28C and coarsely powdered.
The crude aqueous extract was defatted with petroleum
ether and the remaining defatted extract was fractionated
with ethyl acetate (1:1 volume/volume) to obtain the ethyl
acetate fraction (ABAEE-yield: 5%), which was concentrated
and used for the experimental study.
2.3. Experimental animals
Two-month-old male Sprague Dawley rats (200e220 g body
weight; 35 animals in total) bred in our departmental animal
house were used for the study. Animals were housed in
polypropylene cages and maintained under standard condi-
tions [12-hour light/dark cycles, (25 ± 10C)]. Animal care was
performed per the guidelines of the Committee for the Pur-
pose of Control and Supervision of Experiments on Animals
and the experimental protocol approved by the Institutional
Animals Ethics Committee [IAEC-KU- 20/2013-14-BC-SM (22)].
2.4. Induction of experimental diabetes
Ratswere rendereddiabetic bya single intraperitoneal injection
of freshly prepared STZ at a dose of 40 mg/kg body weight in
0.1M citrate buffer (pH 4.5) [10]. The animalswere administered
a 5% glucose solution by dissolving in drinkingwater overnight
to overcome drug-induced hypoglycemia. Following STZ in-
jection (48 hours), blood glucose levelsweremeasured, and rats
with blood glucose levels between 200 mg/dL and 400 mg/dL
were considered diabetic and used for the experiment.
2.5. Experimental design
Dose-dependent toxicity studies were previously performed
in our laboratory using three different doses of ABAEE (5 mg/
kg body weight, 10 mg/kg body weight, and 25 mg/kg body
weight), and the extract at an optimal dose of 25 mg/kg body
weight was found to be effective and safe compared with the
other two doses (5 mg/kg body weight and 10 mg/kg body
weight). Therefore, the dose of 25 mg/kg body weight was
selected for the present study, and the results were compared
with a standard antidiabetic drug metformin.
The experimental animals were divided into five groups,
with each group comprising of seven rats. ABAEE and met-
formin were administered orally using an intragastric tube
once daily in the morning after food delivery for 60 days.
Metformin is generally recommended as a first-line treatment
for diabetes.
Group I: normal control rats.
Group II: normal rats treated with ABAEE (25 mg/kg body
weight).bi fruits attenuate hyperglycemia-mediated oxidative stress in
sis (2016), http://dx.doi.org/10.1016/j.jfda.2016.06.007
Figure 1 e Serum glucose. Values are expressed as
mean ± standard error of the mean of seven rats in each
group. Significance determined at p < 0.05. * Denotes
statistical significance as compared with the normal group.
** Denotes statistical significance as compared with the
diabetic group. ABAEE ¼ ethyl acetate fraction of Averrhoa
bilimbi Linn fruits; DM ¼ diabetes mellitus;
DM þ ABAEE ¼ STZ-induced diabetic rats treated with the
ethyl acetate fraction of Averrhoa bilimbi fruits at a dose of
25 mg/kg body weight/day; DM þ metformin ¼ STZ-
induced diabetic rats treated with metformin at a dose of
100 mg/kg body weight/day; N ¼ normal control rats;
N þ ABAEE ¼ normal rats treated with the ethyl acetate
fraction of Averrhoa bilimbi fruits ; STZ ¼ streptozotocin.
j o u rn a l o f f o o d and d r u g a n a l y s i s x x x ( 2 0 1 6 ) 1e9 3Group III: diabetic control rats.
Group IV: diabetic rats treated with ABAEE (25 mg/kg body
weight).
Group V: diabetic rats treated with metformin (100 mg/kg
body weight).
During the experimental period, body weight, blood
glucose, and physical examinations were determined at reg-
ular intervals. The dosage was adjusted weekly according to
changes in body weight in order to maintain similar doses per
kg body weight in rats over the entire study period for each
group. After 60 days, the rats were sacrificed by sodium
pentothal injection, and blood and hepatic tissue were
collected for various experimental analyses.
2.6. Biochemical parameters
Serum glucose (Agappe Diagnostics, Kerala, India) and gly-
cated hemoglobin (HbA1c) were measured based on the ion-
exchange method [11]. Insulin was measured using an
enzyme-linked immunosorbent assay kit (DRG Diagnostics,
Marburg, Germany). Liver-toxicity markers alanine trans-
aminase (ALT) and aspartate transaminase (AST) were
measured using commercially available assay kits (Agappe
Diagnostics). The activities of antioxidant enzymes superox-
ide dismutase (SOD) [12], catalase (CAT) [13], glutathione
peroxidase (GPx) [14], and glutathione reductase (GRd) [15]
were assayed. Reduced glutathione (GSH) content [16] in the
liver were also measured. Thiobarbituric acid-reactive sub-
stances (TBARS), hydroperoxides (HP), and conjugated dienes
(CD) [17] were also assessed.
2.7. Histopathological analysis
The whole liver from each animal was collected in 10%
formalin solution and immediately processed using the
paraffin technique. Thin sections (5 mm) were cut and stained
with hematoxylin and eosin. The tissue samples were exam-
ined and photographed under a light microscope for obser-
vation of structural abnormality [18].
2.8. High-performance liquid chromatography analysis
High-performance liquid chromatography (HPLC) analysiswas
performed using the HPLC Waters 2695 system (Waters, Mil-
ford,MA, USA), and the separation of ABAEEwas completed by
isocratic gradient elution using a C18 column (4.6mm internal
diameter  250 mm; 5 m particle size). The mobile phase con-
sisted ofmethanol (eluent A) and acetonitrile (eluent B) at a 1:1
ratio, the total flow ratewas 1.0mL/min, and the analysis time
was 15 minutes. The detector wavelength was set at 275 nm.
The injection volume was 20 mL, and the temperature of the
column was 40C. The chromatographic peaks of the analytes
were confirmed and quantified by comparing their retention
time and area using quercetin as the standard.
2.9. Statistical analysis
Values were expressed as mean ± standard error of the mean.
Statistical analyses were performed by one-way analysis ofPlease cite this article in press as: Kurup SB, Mini S, Averrhoa bilim
streptozotocin-induced diabetic rats, Journal of Food and Drug Analyvariance using SPSS version 17 (SPSS, Inc., Chicago, IL, USA).
Duncan's post hoc multiple-comparison tests were used to
determine significant differences among groups. p < 0.05 was
considered to be significant.3. Results
3.1. Serum glucose, HbA1c, and plasma insulin
We measured levels of serum glucose, HbA1c, and plasma
insulin in the different experimental groups (Figs. 1e3). We
observed a significant elevation in serum glucose and HbA1c
in the diabetic group as compared with normal control rats.
However, oral administration of ABAEE and metformin to
diabetic rats significantly reduced (p< 0.05) the levels of serum
glucose and HbA1c as compared with those observed in dia-
betic control rats. No significant deviation was observed in
normal rats treated with ABAEE. Serum glucose and HbA1c
levels were comparable in diabetic rats treated with ABAEE
and metformin.
Plasma insulin levels decreased significantly in the diabetic
group as compared with other groups. Administration of
ABAEE and metformin to diabetic rats significantly increased
(p < 0.05) the level of plasma insulin as compared with levels
measured in diabetic control rats.
3.2. Hepatic toxicity markers
Table 1 shows the activities of hepatic toxicity markers (ALT
and AST) in the normal and experimental groups. The level of
hepatic toxicity markers in normal rats treated with ABAEE
did not show any statistical difference as compared with
levels observed in normal control rats. In contrast, these
pathophysiological indices in diabetic rats were significantlybi fruits attenuate hyperglycemia-mediated oxidative stress in
sis (2016), http://dx.doi.org/10.1016/j.jfda.2016.06.007
Table 1 e Hepatic toxicity markers.
Groups ALT (U/L) AST (U/L)
N 40.95 ± 1.60 54.60 ± 2.14
N þ ABAEE 39.00 ± 1.53 53.50 ± 2.29
DM 87.75 ± 3.44* 96.50 ± 3.82*
DM þ ABAEE 59.13 ± 2.20** 72.15 ± 2.83**
DM þ metformin 72.15 ± 2.83**, *** 85.80 ± 3.36**, ***
Values are expressed as mean ± standard error of the mean of
seven rats in each group. Significance determined at p < 0.05.
* Denotes statistical significance as compared with the normal
group.
** Statistical significance as compared with the diabetic group.
*** Statistical significance as compared with the ABAEE-treated
diabetic group.
ABAEE ¼ ethyl acetate fraction of Averrhoa bilimbi Linn fruits;
ALT ¼ alanine transaminase; AST ¼ aspartate transaminase;
DM ¼ diabetes mellitus; DM þ ABAEE ¼ streptozotocin-induced
diabetic rats treated with the ethyl acetate fraction of A. bilimbi
fruits at a dose of 25 mg/kg body weight/day;
DM þ metformin ¼ streptozotocin-induced diabetic rats treated
with metformin at a dose of 100 mg/kg body weight/day;
N ¼ normal control rats; N þ ABAEE ¼ normal rats treated with the
ethyl acetate fraction of A. bilimbi fruits.
Figure 2 e Glycated hemoglobin. Values are expressed as
mean ± standard error of the mean of seven rats in each
group. Significance determined at p < 0.05. * Denotes
statistical significance as compared with the normal group.
** Statistical significance as compared with the diabetic
group. ABAEE ¼ ethyl acetate fraction of Averrhoa bilimbi
fruits; DM ¼ diabetes mellitus; DM þ ABAEE ¼ STZ-
induced diabetic rats treated with the ethyl acetate fraction
of Averrhoa bilimbi fruits at a dose of 25mg/kg body weight/
day; DM þ metformin ¼ STZ-induced diabetic rats treated
with metformin at a dose of 100 mg/kg body weight/day;
N ¼ normal control rats; N þ ABAEE ¼ normal rats treated
with the ethyl acetate fraction of Averrhoa bilimbi fruits;
STZ ¼ streptozotocin.
j o u r n a l o f f o o d and d r u g an a l y s i s x x x ( 2 0 1 6 ) 1e94(p < 0.05) elevated (87.75 ± 3.44 U/L and 96.50 ± 3.82 U/L,
respectively) as compared with those measured in normal
control rats (40.95 ± 1.60 U/L and 54.60 ± 2.14 U/L, respec-
tively). Oral administration of ABAEE and metformin toFigure 3 e Plasma insulin. Values are expressed as
mean ± standard error of the mean of seven rats in each
group. Significance determined at p < 0.05. * Denotes
statistical significance as compared with the normal group.
** Statistical significance as compared with the diabetic
group. *** statistical significance as compared with the
ABAEE treated diabetic group. ABAEE ¼ ethyl acetate
fraction of Averrhoa bilimbi Linn fruits; DM ¼ diabetes
mellitus; DM þ ABAEE ¼ STZ-induced diabetic rats treated
with the ethyl acetate fraction of Averrhoa bilimbi fruits at a
dose of 25 mg/kg body weight/day;
DM þmetformin ¼ STZ-induced diabetic rats treated with
metformin at a dose of 100 mg/kg body weight/day;
N ¼ normal control rats; N þ ABAEE ¼ normal rats treated
with the ethyl acetate fraction of Averrhoa bilimbi fruits;
STZ ¼ streptozotocin.
Please cite this article in press as: Kurup SB, Mini S, Averrhoa bilim
streptozotocin-induced diabetic rats, Journal of Food and Drug Analydiabetic rats significantly (p < 0.05) decreased the altered
levels of ALT and AST as comparedwith levels in diabetic rats.
However, the levels of hepatic toxicity markers decreased
significantly in ABAEE-treated diabetic rats as compared with
metformin-treated diabetic rats.
3.3. Hepatic antioxidant enzymes
The activities of the antioxidant enzymes CAT, GPx, GRd, and
SOD decreased significantly (p < 0.05) in STZ-induced diabetic
rats as compared with levels observed in the normal control
group. However, oral administration of ABAEE significantly
(p < 0.05) increased the activities of antioxidant enzymes in
the diabetic group, and ABAEE-treated diabetic rats showed a
significant increase in the activities of antioxidant enzymes
relative to those observed in metformin-treated diabetic rats
(Table 2).
3.4. Lipid peroxidation products and reduced GSH
content in liver
Table 3 illustrates the levels of TBARS, HP, and CD in the he-
patic tissues of control and experimental rats. Administration
of ABAEE to normal rats did not result in statistically different
levels of lipid peroxides as compared with levels observed in
normal control rats. The significant (p < 0.05) elevation
observed in the levels of TBARS, HP and CD in the hepatic
tissues of diabetic rats declined (p < 0.05) significantly to near
normal levels following ABAEE or metformin treatment,
although the effect was more significant in ABAEE-treated
diabetic rats as compared with those observed in
metformin-treated diabetic rats.
The level of the hepatic non-enzymatic antioxidant GSH is
shown in Table 3. No significant statistical deviation was
observed in the levels of hepatic GSH in normal rats treated
with ABAEE; however, diabetic rats showed a significantbi fruits attenuate hyperglycemia-mediated oxidative stress in
sis (2016), http://dx.doi.org/10.1016/j.jfda.2016.06.007
Table 2 e Hepatic antioxidant enzymes.
Groups CAT ( 103 U/mg protein) GPx (U/mg protein) GRd (U/mg protein) SOD (U/mg protein)
N 6.84 ± 0.25 26.71 ± 0.99 138.86 ± 5.17 1.35 ± 0.05
N þ ABAEE 7.1 ± 0.27 27.8 ± 1.07 141.29 ± 5.26 1.58 ± 0.06
DM 2.94 ± 0.11* 14.25 ± 0.53* 96.49 ± 3.60* 0.40 ± 0.02*
DM þ ABAEE 4.84 ± 0.18** 19.41 ± 0.73** 121.09 ± 4.51** 0.88 ± 0.03*
DM þ metformin 4.00 ± 0.15**,*** 16.61 ± 0.62*** 104.55 ± 3.82 *** 0.67 ± 0.02**,***
Values are expressed as mean ± standard error of the mean of seven rats in each group. Significance determined at p < 0.05.
* Denotes statistical significance as compared with the normal group.
** Statistical significance as compared with the diabetic group.
*** Statistical significance as compared with the ABAEE-treated diabetic group.
ABAEE¼ ethyl acetate fraction ofAverrhoa bilimbi Linn fruits; CAT¼ catalase; GPX¼ glutathione peroxidase, GRd¼ glutathione reductase; SOD¼
superoxide dismutase; DM ¼ diabetes mellitus; DM þ ABAEE ¼ STZ-induced diabetic rats treated with the ethyl acetate fraction of A. bilimbi
fruits at a dose of 25 mg/kg body weight/day; DM þmetformin ¼ STZ-induced diabetic rats treated with metformin at a dose of 100 mg/kg body
weight/day; N ¼ normal control rats; N þ ABAEE ¼ normal rats treated with the ethyl acetate fraction of A. bilimbi fruits; STZ ¼ streptozotocin.
Table 3 e Lipid peroxidation products and reduced glutathione content (GSH) in liver.
Groups TBARS (mM/100 g tissue) CD (mM/100 g tissue) HP (mM/100 g tissue) GSH content (mM/100 g tissue)
N 0.40 ± 0.02 3.60 ± 0.13 7.81 ± 0.29 62.85 ± 2.37
N þ ABAEE 0.38 ± 0.02 3.51 ± 0.13 7.65 ± 0.28 66.45 ± 2.47
DM 0.84 ± 0.03* 8.62 ± 0.32* 23.75 ± 0.88* 41.18 ± 1.54*
DM þ ABAEE 0.63 ± 0.02** 5.09 ± 0.19** 16.61 ± 0.61** 49.31 ± 1.84**
DM þ Metformin 0.76 ± 0.03**,*** 7.80 ± 0.31**,*** 20.00 ± 0.76**,*** 43.84 ± 1.75***
Values are expressed as mean ± standard error of the mean of seven rats in each group. Significance determined at p < 0.05.
* Denotes statistical significance as compared with the normal group.
** Statistical significance as compared with the diabetic group.
*** Statistical significance as compared with the ABAEE-treated diabetic group.
ABAEE ¼ Averrhoa bilimbi Linn fruits; TBARS ¼ thiobarbituric acid-reactive substances; CD ¼ conjugated dienes; HP ¼ hydroperoxides; GSH ¼
reduced glutathione content; DM ¼ diabetes mellitus; DM þ ABAEE ¼ STZ-induced diabetic rats treated with the ethyl acetate fraction of A.
bilimbi fruits at a dose of 25mg/kg bodyweight/day; DMþmetformin¼ STZ-induced diabetic rats treated withmetformin at a dose of 100mg/kg
body weight/day; N ¼ normal control rats; N þ ABAEE ¼ normal rats treated with the ethyl acetate fraction of A. bilimbi fruits;
STZ ¼ streptozotocin.
j o u rn a l o f f o o d and d r u g a n a l y s i s x x x ( 2 0 1 6 ) 1e9 5(p < 0.05) reduction in GSH level (41.18 ± 1.54 mM/100 g tissue)
as compared with that observed in normal control rats
(62.85 ± 2.36 mM/100 g tissue). Conversely, diabetic rats
treated with ABAEE exhibited significantly (p < 0.05) increased
GSH levels as compared with those measured in diabetic
control rats. Additionally, ABAEE-treated diabetic rats showed
a significant increase in GSH levels relative to those observed
in metformin-treated diabetic rats.
3.5. Histopathological analysis of the liver
Histopathological analysis of the liver from normal control
and normal rats treated with ABAEE indicated normal cell
morphology with hexagonal lobular architecture (Figures 4A
and B). While the STZ-induced diabetic group (Figure 4C)
exhibited hepatocellular damage in the form of mild sinusoi-
dal dilation and focal inflammatory hepatic cell infiltration,
diabetic rats treated with ABAEE or metformin exhibited less
inflammation, with restored cell morphology to almost
normal levels (Figures 4D and E).
3.6. HPLC profiling of ABAEE
HPLC profiling of ABAEE (Figure 5A) showed that it contains
quercetin [6% (weight/weight)] as a major compound
compared with a corresponding reference standard. ThePlease cite this article in press as: Kurup SB, Mini S, Averrhoa bilim
streptozotocin-induced diabetic rats, Journal of Food and Drug Analypresence of quercetin was confirmed by comparing the
retention time of ABAEE (2.449 minutes) with that of the
quercetin standard (2.438 minutes). Therefore, the activity
associated with ABAEE may be attributed to the presence of
the phenolic compound quercetin.4. Discussion
Diabetes is characterized by hyperglycemia with a marked
reduction in insulin secretion and insulin function [19]. Over
the long term, hyperglycemia generates excess ROS, which
induces oxidative stress. Under physiological conditions,
antioxidant enzymes protect cells against harmful free radi-
cals. A number of plant-derived products possess hypoglyce-
mic, hypolipidemic, and antioxidant properties [20].
Low doses of STZ (40 mg/kg body weight) destroy pop-
ulations of pancreatic b-cells in rats, leading to insufficient
insulin secretion and resulting in moderate and stable hy-
perglycemia and glucose intolerance that contributes to a
number of features similar to type 2 diabetes mellitus [21].
Therefore, STZ-induced diabetes in rats was chosen as the
animal model for the present investigation.
Our results confirmed the antihyperglycemic and antioxi-
dant effects of the ethyl acetate fraction of ABAEE in STZ-
induced diabetic rats. HPLC analysis of ABAEE revealed thebi fruits attenuate hyperglycemia-mediated oxidative stress in
sis (2016), http://dx.doi.org/10.1016/j.jfda.2016.06.007
Figure 4 e Photomicrographs of hematoxylin-eosin staining of hepatic tissue from control and experimental rat groups.
Diabetes was induced by single intraperitoneal injection of streptozotocin (STZ; 40 mg/kg body weight). Averrhoa bilimbi
Linn fruits (ABAEE; 25 mg/kg body weight/day) was orally administered daily for 60 days. At the end of the experimental
period, rats were sacrificed, and the hepatic tissues were sectioned for histological study. (A) Normal control rats; (B) normal
rats treated with the ethyl acetate fraction of A. bilimbi fruits; (C) STZ-induced diabetic rats; (D) STZ-induced diabetic rats
treated with the ethyl acetate fraction of A. bilimbi fruits at a dose of 25 mg/kg body weight/day; (E) STZ-induced diabetic rats
treated with metformin at a dose of 100 mg/kg body weight/day.
j o u r n a l o f f o o d and d r u g an a l y s i s x x x ( 2 0 1 6 ) 1e96presence of quercetin, and studies reported that quercetin
exerts antidiabetic properties by enhancing pancreatic
secretion of insulin from b-cells in STZ-induced models [22].
Experimentally-induced diabetic rats showed severe hy-
perglycemia interconnected with reduced insulin secretion
and release. Here, fasting blood glucose was significantly
elevated in diabetic control rats, which might be due to
pancreatic b-cell damage. Administration of ABAEE or met-
formin significantly reduced elevated blood glucose levels,
possibly through increased release of insulin from existing
and/or regenerated pancreatic b-cells.
Nonenzymatic and auto-oxidative glycosylation are
mechanisms linking hyperglycemia and vascular complica-
tions associated with diabetes mellitus. Increased levels of
HbA1c indicate that erythrocytes are more prone to oxidative
stress in diabetes patients. High levels of HbA1c are found in
diabetes patients, and this increase in HbA1c is directly pro-
portional to fasting blood glucose levels [23,24]. In agreement
with previous reports, our results show significantly increased
HbA1c levels in the diabetic group; however, a significant
decrease in HbA1c levels was observed in ABAEE- and
metformin-treated groups. Decreased levels of HbA1c in
ABAEE-treated diabetic rats indicated the beneficial effects of
ABAEE in preventing the pathogenesis of diabetic complica-
tions caused by impaired glucose metabolism.
Diabetes is often associated with elevated activities of
liver-marker enzymes, such as AST and ALT, in serum, which
might be due to leakage of these enzymes from the liver into
the bloodstream [25] and an indication of the toxic effects of
STZ treatment. Consistent with the previous reports, ALT and
AST activities increased significantly in STZ-induced diabetic
rats; however, ABAEE or metformin administration reducedPlease cite this article in press as: Kurup SB, Mini S, Averrhoa bilim
streptozotocin-induced diabetic rats, Journal of Food and Drug AnalyALT and AST activities in diabetic rats, with a greater reduc-
tion observed following ABAEE treatment. The alterations in
biochemical activity were supported by histological profiles.
Decreases in ALT and AST activity in treated diabetic rats
suggested that ABAEE exhibits therapeutic effects in hepatic
disorders, in addition to its insulin secretagogue and anti-
hyperglycemic activities. Additionally, the activities associ-
ated with liver-toxicity markers were not altered in the
ABAEE-treated group as compared with the normal control
group. These results indicated that ABAEE treatment was safe
and exerted no significant toxicity.
Hyperglycemia causes an increased production of ROS
along with reduced antioxidant status, increased lipid perox-
idation, and impaired glucose metabolism in biological sys-
tems [26]. The liver plays a major role in the regulation of
glucosemetabolism, andvarious studiesobserved inductionof
severe oxidative stress in the liver of STZ-induced diabetic rats
[27]. The activities of the principal enzymatic and nonenzy-
matic antioxidant systems decrease during oxidative stress
[28]. In agreement with previous reports, our results showed
that the activities of the antioxidant enzymes CAT, GPx, GRd,
and SOD were significantly decreased in the diabetic control
group; however, oral administration of ABAEE or metformin
increased the antioxidant potential of the liver by increasing
CAT, GPx, GRd, and SOD activity in diabetic rats [29]. Our
findings showedmaximumantioxidant activity in liver tissues
from ABAEE-treated diabetic rats, which was slightly greater
than that observed in metformin-treated diabetic rats.
GSH is an intracellular tripeptide that constitutes themajor
reducing capacity of the cytoplasm [30]. GSH protects cells
against the toxic effects of lipid peroxidation [31], and
exhaustion of GSH results in enhanced lipid peroxidation,bi fruits attenuate hyperglycemia-mediated oxidative stress in
sis (2016), http://dx.doi.org/10.1016/j.jfda.2016.06.007
Figure 5 e High-performance liquid chromatography (HPLC): (A) HPLC profiling of ethyl acetate fraction of Averrhoa bilimbi
fruits; (B) HPLC chromatogram of standard quercetin.
j o u rn a l o f f o o d and d r u g a n a l y s i s x x x ( 2 0 1 6 ) 1e9 7which can cause increased GSH consumption correlated with
increased levels of oxidized GSH [32]. In agreement with pre-
vious reports, we observed significant decreases in GSH levels
in diabetic rats; however, supplementation with ABAEE or
metformin elevated GSH levels, enabling the protection of the
cell membrane against oxidative damage by regulating the
redox status of membrane proteins [33]. Levels of tissue GSH
increased to a greater extent in ABAEE-treated diabetic rats
relative to the increased levels observed inmetformin-treated
diabetic rats. Our results suggested that ABAEE providedPlease cite this article in press as: Kurup SB, Mini S, Averrhoa bilim
streptozotocin-induced diabetic rats, Journal of Food and Drug Analyantioxidant potential and protected diabetic rats from sec-
ondary complications due to increased oxidative stress.
Lipid peroxides are released as a result of the toxic effects
associated with ROS produced during lipid peroxidation in
diabetes [34], and measurement of TBARS is considered the
most reliable marker to assess the extent of lipid peroxidation
[35]. Lipid peroxidation is characterized by enhanced con-
centrations of TBARS, HP, and CD in diabetic rats [36]. Oral
administration of ABAEE or metformin restored levels of liver
TBARS, HP, and CD to near normal ranges in diabetic rats,bi fruits attenuate hyperglycemia-mediated oxidative stress in
sis (2016), http://dx.doi.org/10.1016/j.jfda.2016.06.007
j o u r n a l o f f o o d and d r u g an a l y s i s x x x ( 2 0 1 6 ) 1e98indicating the cytoprotective and free radical-scavenging
properties of both treatments. We observed greater re-
ductions in peroxidative markers in the tissues of ABAEE-
treated diabetic rats relative to reductions observed in
metformin-treated diabetic rats.
Previous studies showed that the liver was necrotized in
STZ-induced diabetic rats [37,38]. Consistent with these re-
ports, we observedmarked hepatocellular damage in the form
of mild sinusoidal dilation and focal inflammatory cell infil-
tration in STZ-induced diabetic rats. In comparison with the
diabetic group, the administration of ABAEE or metformin
significantly improved the histological architecture of the
liver. Additionally, serum ALT and AST levels increased
significantly in diabetic rats, but maintained near normal
levels following treatment with ABAEE. These findings sug-
gested that ABAEE administration was capable of reducing
STZ-induced oxidative stress and hepatic damage.
HPLC analysis of ABAEE revealed the presence of quercetin
(6%) as a major compound. Quantification indicated that 100 g
of dried ABAEE material possessed 6 g of quercetin. Previous
studies showed that quercetin supplementation improves
glucose tolerance in STZ-induced diabetic rats [39]. Quercetin
also protects STZ-induced diabetic rats from oxidative dam-
age and preserves pancreatic b-cell integrity [40,41]. The
potent antioxidant activity of ABAEE may be attributed to the
presence of quercetin.5. Conclusion
The results of this study indicate that administration of
ABAEE at a dose of 25 mg/kg body weight significantly reduce
hyperglycemia and oxidative stress in STZ-induced diabetic
rats. Thismay bemediated by the activity of quercetin present
in ABAEE. Further detailed studies are in progress to elucidate
the exact mechanism by which the ethyl acetate fraction of
ABAEE elicits its modulatory effects.Conflicts of interest
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